Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SUNITINIB KOANAA 37,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/SUNITINIB KOANAA 37,5 MG CAPSULAS DURAS EFG

Approved

STANDARD

SUNITINIB KOANAA 37,5 MG CAPSULAS DURAS EFG

Koanaa Healthcare Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 23, 2022
Approval ID: e216842950dc73da
Company: Koanaa Healthcare Gmbh
Type: Standard

Approval Details

Approval Id: e216842950dc73da
Drug Cima Aemps Name: SUNITINIB KOANAA 37,5 MG CAPSULAS DURAS EFG
Register Number: 86619
Holder Company Name: Koanaa Healthcare Gmbh
Marketing Company Name: Koanaa Healthcare Gmbh
Authorization Date: 2022-05-23
Dosage Form: CÁPSULA DURA
Dose: 37,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Koanaa Healthcare Gmbh

Active Ingredients

SUNITINIB MALATO

50,123 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 23, 2022

Approval ID

e216842950dc73da

Type

Standard

Back to CIMA-AEMPS Approvals